Cargando…

NIV IN MODERATE TO SEVERE ARDS DUE TO COVID-19 PNEUMONIA: A RETROSPECTIVE COHORT STUDY

Detalles Bibliográficos
Autores principales:	BOTSCH, A., ORAVEC, M., RAPIER, B., GOFF, L., DESMETT, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians. Published by Elsevier Inc. 2022
Materias:	E-Poster Viewing Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212407/ http://dx.doi.org/10.1016/j.chest.2022.04.135

Ejemplares similares

RADIOLOGICAL PHENOTYPES' IN COVID-19 PNEUMONIA: RETROSPECTIVE, MULTICENTRIC STUDY OF 6000 CASES IN TERTIARY CARE SETTING IN INDIA
por: PATIL, S., et al.
Publicado: (2022)

SPONTANEOUS PNEUMOMEDIASTINUM IN COVID-19 PNEUMONIA
por: BELTRAN, L., et al.
Publicado: (2022)

Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study
por: Ding, Lin, et al.
Publicado: (2020)

LONG-TERM EVOLUTION OF RESPIRATORY IMPAIRMENT AFTER ACUTE RESPIRATORY FAILURE DUE TO COVID-19
por: DANIELE, F., et al.
Publicado: (2022)

308. Secondary Infections in Patients Requiring Extracorporeal Membrane Oxygenation (ECMO) for Severe Acute Respiratory Distress Syndrome (ARDS) due to COVID-19 Pneumonia (PNA)
por: Rivosecchi, Ryan, et al.
Publicado: (2021)

Outcomes of patients receiving non-invasive ventilation (NIV) in the general intensive care unit: is NIV duration an important factor?
por: Wilson, L, et al.
Publicado: (2015)

Breathing pattern, accessory respiratory muscles work, and gas exchange evaluation for prediction of NIV failure in moderate-to-severe COVID-19-associated ARDS after deterioration of respiratory failure outside ICU: the COVID-NIV observational study
por: Yaroshetskiy, Andrey I., et al.
Publicado: (2022)

Portable NIV for patients with moderate to severe COPD: two randomized crossover trials
por: Majorski, Daniel Sebastian, et al.
Publicado: (2021)

Rapid and Impressive Response to a Combined Treatment with Single-Dose Tocilizumab and NIV in a Patient with COVID-19 Pneumonia/ARDS
por: Cascella, Marco, et al.
Publicado: (2020)

NIV through the helmet can be used as first-line intervention for early mild and moderate ARDS: an unproven idea thinking out of the box
por: Antonelli, Massimo
Publicado: (2019)

Microcirculatory alterations are associated with pulmonary dead-space fraction in moderate and severe ards
por: Ospina-Tascón, GA, et al.
Publicado: (2015)

THE IMPACT OF COVID 19 ON THE PRACTICE OF PALLIATIVE RADIOTHERAPY: EXPERIENCE OF RADIOTHERAPY ONCOLOGY DEPARTMENT OF CANCER CENTER TLEMCEN, ALGERIA
por: Mous, A.
Publicado: (2022)

ELECTRON MICROSCOPIC STUDY OF THE LUNGS OF DECEASED PATIENTS WITH COVID-19
por: GONZÁLEZ, A. VIDAL, et al.
Publicado: (2022)

EVOLUTION OF THE TB ENDEMIC DURING THE COVID-19 PANDEMIC IN A GEOGRAPHIC AREA WITH AN INCREASED INCIDENCE IN ROMANIA
por: STANCIU, I.-V., et al.
Publicado: (2022)

IMPACT OF PULMONARY REHABILITATION ON AEROBIC CAPACITY AND QUALITY OF LIFE ON PATIENTS POST-COVID-19
por: MOTTA, J.A. RIVERA, et al.
Publicado: (2022)

THE CLINICAL-EVOLUTIVE SPECTRUM OF COVID-19 IN A GERIATRIC, MULTIMORBID POPULATION
por: CÎRJALIU, R.-E., et al.
Publicado: (2022)

COMPARISON OF THREE DIFFERENT AI-BASED SOFTWARE FOR QUANTIFICATION OF LUNG PARENCHYMA IN PATIENTS WITH COVID-19
por: NICOLÒ, M., et al.
Publicado: (2022)

Severe community acquired pneumonia and ARDS: prognostic factors in infants
por: Chidini, G, et al.
Publicado: (2003)

Weaning from NIV: how rapidly can we go?
por: Chico, J, et al.
Publicado: (2011)

498. Baricitinib in Patients with Severe Pneumonia due to COVID-19 in Veracruz, Mexico
por: Del Carpio-Orantes, Luis, et al.
Publicado: (2021)

Promoting NIV using ICEMAN methodology
por: Sundaram, Manu, et al.
Publicado: (2019)

THE EVALUATION OF SERUM ANGIOTENSIN CONVERTING ENZYME 2 (ACE2) LEVELS AND ITS RELATIONSHIP WITH CLINICAL OUTCOME IN PATIENTS WITH COVID-19
por: HOSSEINIB, M., et al.
Publicado: (2022)

FOLLOW-UP OF PULMONARY EMBOLISM IN PATIENTS WITH COVID-19
por: FILIPPI, L., et al.
Publicado: (2022)

PROSPECTIVE ANALYSIS OF THE PHYSIOLOGICAL CHANGES CAUSED BY PROLONGED USE OF N95-TYPE MASKS
por: EVMAN, S., et al.
Publicado: (2022)

POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME: POSSIBLY COVID VACCINE RELATED
por: BARAL, M., et al.
Publicado: (2022)

GUILLAIN-BARRÉ SYNDROME IN A PATIENT POST-COVID-19 IN THE PHILIPPINES: A CASE REPORT
por: GONNAD, M.K., et al.
Publicado: (2022)

LONG COVID IN POST-COVID-19 CARE SETTING: PROSPECTIVE, OBSERVATIONAL, AND INTERVENTIONAL STUDY OF 6,000 CASES IN TERTIARY CARE SETTING IN INDIA
por: PATIL, S., et al.
Publicado: (2022)

SYSTEMIC CAPILLARY LEAK SYNDROME: WHAT IS THE TRIGGER; COVID-19 INFECTION OR VACCINATION?
por: MADALA, N., et al.
Publicado: (2022)

ASSOCIATION OF CHEST RADIOGRAPHIC BRIXIA SCORE AND IN-HOSPITAL MORTALITY AMONG FILIPINO PATIENTS WITH CONFIRMED COVID-19 AT A SINGLE MEDICAL CENTER
por: MIRAL, M., et al.
Publicado: (2022)

Initial pH and mortality in patients with exacerbations of COPD and pneumonia treated with NIV in a teaching hospital critical care unit
por: Goodhart, IM, et al.
Publicado: (2015)

Comparison of efficacy of different ventilators to administer NIV in healthy subjects
por: Chatterjee, S, et al.
Publicado: (2002)

Efficacy, safety and side effects of noninvasive mechanical ventilation (NIV) in an internal medicine ward
por: Puleo, A, et al.
Publicado: (2015)

NIV-Helmet in Severe Hypoxemic Acute Respiratory Failure
por: Martins, Joana, et al.
Publicado: (2015)

Comparing trends in the use and outcomes of non invasive ventilation (NIV) in a general intensive care unit
por: Wilson, L, et al.
Publicado: (2015)

Maschinelle Beatmung und NIV
por: Larsen, Reinhard
Publicado: (2016)

A Retrospective Analysis of Ventilatory Strategy Comparing Non-invasive Ventilation (NIV) With Invasive Ventilation in Patients Admitted With Severe COVID-19 Pneumonia
por: Srinivasaiah, Madhu, et al.
Publicado: (2023)

The optimal management of the patient with COVID-19 pneumonia: HFNC, NIV/CPAP or mechanical ventilation?
por: Broadhurst, A G B, et al.
Publicado: (2022)

292. Antibiotic Use Is Increased in Patients with Acute Respiratory Distress Syndrome (ARDS) Requiring Extracorporeal Membrane Oxygenation (ECMO) due to COVID-19 Compared with Influenza
por: Alex Viehman, J, et al.
Publicado: (2021)

PULSED METHYLPREDNISOLONE USAGE IN ARDS DUE TO VIRAL PNEUMONIA
por: Szeto, C.H.
Publicado: (2019)

Prognostic factors in severe ARDS-patients
por: Friess, U, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_cbs5n9ja08t0i58gi85koe4vde